Silver Book Fact

Following the current path, the lung cancer incidence rate will increase by 34% between 2003 and 2023. If an alternative path is taken, there will be 18.4% (92,000) fewer lung cancer cases in 2023.

DeVol R, Bedroussian A, Charuworn A, et al. An Unhealthy America: The economic burden of chronic disease. The Milken Institute; October 2007. http://www.milkeninstitute.org/publications/publications.taf?function=detail&ID=38801018&cat=ResRep

Reference

Title
An Unhealthy America: The economic burden of chronic disease
Publisher
The Milken Institute
Publication Date
October 2007
Authors
DeVol R, Bedroussian A, Charuworn A, et al
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Since 1975, the five year survival rate for breast cancer patients has increased by 40 percent.  
  • Low dose CT screening for lung cancer costs less than $200 per person, and surgery for stage I lung cancer is less than 1/2 the cost of late-stage treatment.  
  • From 1975 to 1996, new cancer drugs increased life expectancy of cancer patients by about one year, at an estimated cost of $3,000—well below the estimated value of a statistical…  
  • Gains in healthy years of life and social value from cancer R&D
     
  • A 10 percent reduction in cancer-related deaths in the U.S. would be worth an estimated $4.4 trillion to current and future generations.